CapMan Russia, the Russia-focused private equity fund of Finnish asset manager CapMan, has acquired a 25 percent stake in Vital Development Corporation (Vital), a Russian producer of laboratory equipment and biochemical reagents. Vital plans to further expand its product line with two new business lines related to immunological analysis and water purification systems. Financial terms of the transaction were not disclosed.